Do cytomegalovirus infections affect the daratumumab treatment course in multiple myeloma patients? – Literature review

Autor: Mailine Gehrcke, Jaderson Lima Cerezer, Luana Mota Ferreira

Publikováno v: Hematology, Transfusion and Cell Therapy, Vol 43, Iss 2, Pp 185-190 (2021)
Hematology, Transfusion and Cell Therapy
Hematology, Transfusion and Cell Therapy, Volume: 43, Issue: 2, Pages: 185-190, Published: 07 JUL 2021

Introduction Multiple myeloma is a progressive and incurable hematological disease characterized by disordered and clonal multiplication of plasmacytes in the bone marrow. The main clinical manifestations are caused by the presence of neoplastic cell

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1dddbaeec1328b11165e3035965f84ab
http://www.sciencedirect.com/science/article/pii/S2531137920300833